| Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival BC Özdemir, T Pentcheva-Hoang, JL Carstens, X Zheng, CC Wu, ... Cancer cell 25 (6), 719-734, 2014 | 2248 | 2014 |
| TGF-β1–containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis FT Borges, SA Melo, BC Özdemir, N Kato, I Revuelta, CA Miller, ... Journal of the American Society of Nephrology 24 (3), 385-392, 2013 | 445 | 2013 |
| Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival BC Özdemir, T Pentcheva-Hoang, JL Carstens, X Zheng, CC Wu, ... Cancer cell 28 (6), 831-833, 2015 | 190 | 2015 |
| Gender medicine and oncology: report and consensus of an ESMO workshop AD Wagner, S Oertelt-Prigione, A Adjei, T Buclin, V Cristina, C Csajka, ... Annals of Oncology 30 (12), 1914-1924, 2019 | 157 | 2019 |
| Racial differences in cancer susceptibility and survival: more than the color of the skin? BC Özdemir, GP Dotto Trends in cancer 3 (3), 181-197, 2017 | 150 | 2017 |
| Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: an overlooked aspect in immunotherapy E Ghisoni, A Wicky, H Bouchaab, M Imbimbo, J Delyon, BG Moura, ... European Journal of Cancer 149, 153-164, 2021 | 98 | 2021 |
| Sex hormones and anticancer immunity BC Özdemir, GP Dotto Clinical Cancer Research 25 (15), 4603-4610, 2019 | 96 | 2019 |
| Sex differences in efficacy and toxicity of systemic treatments: an undervalued issue in the era of precision oncology. BC Özdemir, C Csajka, GP Dotto, AD Wagner Journal of clinical oncology: official journal of the American Society of …, 2018 | 95 | 2018 |
| The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell … BC Özdemir, J Hensel, C Secondini, A Wetterwald, R Schwaninger, ... PloS one 9 (12), e114530, 2014 | 54 | 2014 |
| Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation A Clocchiatti, S Ghosh, MG Procopio, L Mazzeo, P Bordignon, P Ostano, ... The Journal of clinical investigation 128 (12), 5531-5548, 2018 | 52 | 2018 |
| The challenges of modeling hormone receptor-positive breast cancer in mice BC Özdemir, G Sflomos, C Brisken Endocrine-related cancer 25 (5), R319-R330, 2018 | 42 | 2018 |
| Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis M Ma, S Ghosh, D Tavernari, A Katarkar, A Clocchiatti, L Mazzeo, ... Journal of Experimental Medicine 218 (2), e20201137, 2020 | 34 | 2020 |
| Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors D Arangalage, N Degrauwe, O Michielin, P Monney, BC Özdemir Cancer treatment reviews 100, 102282, 2021 | 30 | 2021 |
| G-CSF induced arteriogenesis in humans: molecular insights into a randomized controlled trial P Meier, S Gloekler, B Oezdemir, A Indermuehle, T Traupe, R Vogel, ... Current vascular pharmacology 11 (1), 38-46, 2013 | 29 | 2013 |
| Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology BC Özdemir Journal for immunotherapy of cancer 9 (2), 2021 | 27 | 2021 |
| Sex and gender differences in anticancer treatment toxicity: a call for revisiting drug dosing in oncology BC Özdemir, CL Gerard, C Espinosa da Silva Endocrinology 163 (6), bqac058, 2022 | 25 | 2022 |
| Long-term follow-up after implantation of the Shelhigh® No-React® complete biological aortic valved conduit DC Reineke, A Kaya, PP Heinisch, B Oezdemir, B Winkler, C Huber, ... European Journal of Cardio-Thoracic Surgery 50 (1), 98-104, 2016 | 24 | 2016 |
| Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis BC Özdemir, S Latifyan, M Perreau, C Fenwick, L Alberio, G Waeber, ... Annals of Oncology 31 (12), 1775-1778, 2020 | 23 | 2020 |
| Deep response to anti-PD-1 therapy of metastatic neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor with CD274/PD-L1 amplification BC Özdemir, P Bohanes, B Bisig, E Missiaglia, P Tsantoulis, G Coukos, ... JCO Precision Oncology 3, 1-6, 2019 | 18 | 2019 |
| Immune-related adverse events of immune checkpoint inhibitors and the impact of sex—what we know and what we need to learn BC Özdemir, G Coukos, AD Wagner Annals of Oncology 29 (4), 1067, 2018 | 18 | 2018 |
